Predict your next investment

Private Equity
FINANCIAL | Investment Banking

See what CB Insights has to offer

Investments

1

Portfolio Exits

1

Funds

1

About Teather & Greenwood

Teather & Greenwood is a private equity firm based out of London, United Kingdom.

Teather & Greenwood Headquarter Location

Beaufort House 15 St Botolph Street

London, EC3A 7QR,

United Kingdom

44 20 7426 9000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Teather & Greenwood News

IPO News and Information - BrainJuicer Group - First Day of Dealings on AiM Teather & Greenwood Landsbanki is the Company's Nominated Adviser and Broker.

Jan 22, 2014

BrainJuicer Group - First Day of Dealings on AiM RNS Number:2330N BrainJuicer Group PLC05 December 2006 Press Release 05 December 2006 BrainJuicer plc ("BrainJuicer" or "the Company") First day of dealings on AiM BrainJuicer Group PLC, one of Europe's leading online market research agencies,today announces the commencement of dealings of its Ordinary Shares on the AiM Market of the London Stock Exchange. The stock market EPIC is BJU. UK based BrainJuicer was established in 1999 to provide quantitative onlineresearch using innovative, bespoke software to produce insightful marketresearch for large multinational companies. BrainJuicer has over 80 clients,including 10 of the world's top 50 companies (FT 500, September 2006) and isregarded as one of the leading innovators in the research industry. The Companyis focused on assisting clients throughout their development process byproviding rich diagnostics to enable clients to better understand consumers andthen identify the strongest product, pack and advertising ideas and how best todevelop them. The Board's objective is to position the Company as aninternational market-leading research agency. Placing and Admission Statistics Number of New Ordinary Shares to be issued pursuant to the Placing 1,388,900 Number of Ordinary Shares in issue immediately following Admission 12,550,613 Percentage of the Company's enlarged issued share capital being placed 11.07 per cent. Market capitalisation of the Company at the Placing Price #13.55 million Gross proceeds of the Placing available to the Company #1.50 million Estimated net proceeds of the Placing receivable by the Company #1.01 million John Kearon, Chairman and Chief Executive of BrainJuicer, commented: "We arepleased that the flotation has been successfully completed and are delightedwith the support received from our new shareholders. BrainJuicer is one of thefirst companies to make full use of the Internet's interactive capabilities,adding deep qualitative understanding to robust quantitative research andreducing research timescales. "The Company's innovative research methodology and bespoke software positions BrainJuicer favourably to tap into the fast growing sector of online marketresearch. The Company aims to remain at the forefront of market research throughdeveloping innovative research techniques to drive the business forward. Welook forward to continued growth. " - Ends - For further information, please contact: BrainJuicer plc John Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000 www.brainjuicer.com Teather & Greenwood Landsbanki James Maxwell / Fred Walsh / Simon Brown Tel: +44 (0)20 7426 9000 www.teathers.com Media enquiries: Heather Salmond / Leena Patel Tel: +44 (0) 20 7398 7704 / +44 (0) 20 7398 7711 Heather.salmond@abchurch-group.com www.abchurch-group.com Photography Photographs are available from Abchurch. To arrange to receive soft copies,please contact Leena Patel on 020 7398 7711 or leena.patel@abchurch-group.com Notes for editors BrainJuicer carries out quantitative online research using innovative, bespokesoftware to produce insightful market research for large, multinationalcompanies, including 10 of the world's top 50 companies (FT 500 September 2006). BrainJuicer operates in a growing sector of the US$23bn global research market,namely quantitative online research. BrainJuicer's main competitors are largetraditional market research providers who have dominated the market for off-linemarket research, such as AC Nielsen, Millward Brown, Research International and Taylor Nelson Sofres. Whilst the largest traditional research companies have developed their ownonline capability, BrainJuicer has a number of key attributes which havecontributed to it achieving rapid growth and winning contracts with prestigiousclients, including:* A scaleable online-only business model. Unlike the traditional researchcompanies who maintain both on and offline data collection capabilities, BrainJuicer is able to focus on operating a scaleable online-only businessmodel. * Research platform that delivers greater diagnostic insight. BrainJuicer hasdeveloped tools and award-winning techniques that enable it to provide a greaterlevel of diagnostic insight into quantitative market research. These techniquesenable clients to enhance their understanding of consumer preference and helpthem make decisions on the best way to develop their products and services. * Speed. BrainJuicer's automated research techniques enable it to conductcomplicated studies very quickly. BrainJuicer's rapid deployment and resultsproduction, even on multi-country studies, provide clients with a speed tomarket advantage in the development of new products and services. To date the Group has conducted projects in over 50 countries and more than 30languages and has established offices in the UK, the Netherlands and the US. The Group's revenues come from full service market research work, and from itsonline Juicy Brains Panel in the UK. - Ends - This information is provided by RNS The company news service from the London Stock Exchange END

Teather & Greenwood Investments

1 Investments

Teather & Greenwood has made 1 investments. Their latest investment was in Businesshealth Group as part of their Series C on May 5, 2001.

CBI Logo

Teather & Greenwood Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/31/2001

Series C

Businesshealth Group

$2.85M

Yes

3i Group, AAC Capital Partners, Harris Nesbitt Gerard, Maven Capital Partners, Undisclosed Angel Investors, and Undisclosed Investors

1

Date

5/31/2001

Round

Series C

Company

Businesshealth Group

Amount

$2.85M

New?

Yes

Co-Investors

3i Group, AAC Capital Partners, Harris Nesbitt Gerard, Maven Capital Partners, Undisclosed Angel Investors, and Undisclosed Investors

Sources

1

Teather & Greenwood Portfolio Exits

1 Portfolio Exit

Teather & Greenwood has 1 portfolio exit. Their latest portfolio exit was Businesshealth Group on August 31, 2005.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/31/2005

Asset Sale

Undisclosed Investors

1

Date

8/31/2005

Exit

Asset Sale

Companies

Valuation

Acquirer

Undisclosed Investors

Sources

1

Teather & Greenwood Fund History

1 Fund History

Teather & Greenwood has 1 fund, including T&G AIM VCT.

Closing Date

Fund

Fund Type

Status

Amount

Sources

5/31/2002

T&G AIM VCT

Multi-Stage Venture Capital

$29.2M

1

Closing Date

5/31/2002

Fund

T&G AIM VCT

Fund Type

Multi-Stage Venture Capital

Status

Amount

$29.2M

Sources

1

Teather & Greenwood Team

2 Team Members

Teather & Greenwood has 2 team members, including current Chief Executive Officer, Ken Ford.

Name

Work History

Title

Status

Ken Ford

Chief Executive Officer

Current

Nicholas Stagg

Chief Operating Officer

Current

Name

Ken Ford

Nicholas Stagg

Work History

Title

Chief Executive Officer

Chief Operating Officer

Status

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.